LEPTOMENINGEAL DISEASE (LMD)
Clinical trials for LEPTOMENINGEAL DISEASE (LMD) explained in plain language.
Never miss a new study
Get alerted when new LEPTOMENINGEAL DISEASE (LMD) trials appear
Sign up with your email to follow new studies for LEPTOMENINGEAL DISEASE (LMD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets deadly brain tumors in first human trial
Disease control Recruiting nowThis study tests a new drug called AZD1390 given together with radiation therapy for people with glioblastoma (a fast-growing brain cancer) or brain tumors that have spread from other cancers. It is the first time this drug is used in humans, so the main goals are to find safe do…
Matched conditions: LEPTOMENINGEAL DISEASE (LMD)
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Spinal fluid biopsy may spot brain metastases early
Knowledge-focused Recruiting nowThis study looks at whether a sample of spinal fluid can find cancer DNA in people whose solid tumors have spread to the brain or its lining. Researchers will compare results from 60 participants with different types of brain involvement. The goal is to see if this liquid biopsy …
Matched conditions: LEPTOMENINGEAL DISEASE (LMD)
Phase: NA • Sponsor: Sunnybrook Health Sciences Centre • Aim: Knowledge-focused
Last updated May 26, 2026 10:31 UTC